Experimental studies have provided evidence that UA may impair insulin signaling in the liver, skeletal muscles and adipose tissues, thus contributing to the pathogenesis of hepatic and systematic insulin resistance-related disorders such as systemic inflammation, liver steatosis, and, eventually, type 2 diabetes [20–23]. This evidence concerns the gene INS and type 2 diabetes mellitus.